首页> 外文期刊>Topics in companion animal medicine >Selective Serotonin Reuptake Inhibitor Exposure
【24h】

Selective Serotonin Reuptake Inhibitor Exposure

机译:选择性5-羟色胺再摄取抑制剂暴露

获取原文
获取原文并翻译 | 示例
       

摘要

Many antidepressants inhibit serotonin or norepinephrine reuptake or both to achieve their clinical effect. The selective serotonin reuptake inhibitor class of antidepressants (SSRIs) includes citalopram, escitalopram (active enantiomer of citalopram), fluoxetine, fluvoxamine, paroxetine, and sertraline. The SSRIs are as effective as tricyclic antidepressants in treatment of major depression with less significant side effects. As a result, they have become the largest class of medications prescribed to humans for depression. They are also used to treat obsessive-compulsive disorder, panic disorders, alcoholism, obesity, migraines, and chronic pain. An SSRI (fluoxetine) has been approved for veterinary use in treatment of canine separation anxiety. SSRIs act specifically on synaptic serotonin concentrations by blocking its reuptake in the presynapse and increasing levels in the presynaptic membrane. Clinical signs of SSRI overdose result from excessive amounts of serotonin in the central nervous system. These signs include nausea, vomiting, mydriasis, hypersalivation, and hyperthermia. Clinical signs are dose dependent and higher dosages may result in the serotonin syndrome that manifests itself as ataxia, tremors, muscle rigidity, hyperthermia, diarrhea, and seizures. Current studies reveal no increase in appearance of any specific clinical signs of serotonin toxicity with regard to any SSRI medication. In people, citalopram has been reported to have an increased risk of electrocardiographic abnormalities. Diagnosis of SSRI poisoning is based on history, clinical signs, and response to therapy. No single clinical test is currently available to confirm SSRI toxicosis. The goals of treatment in this intoxication are to support the animal, prevent further absorption of the drug, support the central nervous system, control hyperthermia, and halt any seizure activity. The relative safety of the SSRIs in overdose despite the occurrence of serotonin syndrome makes them more desirable than other antidepressants. The prognosis in animals that receive treatment is excellent. In one retrospective study, there were no deaths in 313 SSRI-poisoned dogs. No characteristic or classic histopathologic lesions result from SSRI toxicosis. Differential diagnoses for SSRI overdose must include ingestions of other serotonergic medications such as phenylpiperidine opioids (fentanyl and tramadol), mirtazapine, buspirone, amitraz, and chlorpheniramine
机译:许多抗抑郁药会抑制5-羟色胺或去甲肾上腺素的再摄取,或同时达到这两者的临床效果。选择性5-羟色胺再摄取抑制剂类抗抑郁药包括西酞普兰,依他普仑(西酞普兰的活性对映体),氟西汀,氟伏沙明,帕罗西汀和舍曲林。 SSRI与三环类抗抑郁药在重度抑郁症的治疗中效果一样,副作用较小。结果,它们已经成为处方给人类抑郁症的最大药物。它们还用于治疗强迫症,恐慌症,酗酒,肥胖,偏头痛和慢性疼痛。 SSRI(氟西汀)已被批准用于兽医治疗犬分离焦虑症。 SSRI通过阻止突触前5-羟色胺在突触前的再摄取和增加突触前膜的水平来专门作用于5-羟色胺。 SSRI过量的临床体征是由于中枢神经系统中5-羟色胺含量过多所致。这些体征包括恶心,呕吐,瞳孔散大,唾液分泌过多和体温过高。临床体征是剂量依赖性的,较高剂量可能导致血清素综合征,其表现为共济失调,震颤,肌肉僵硬,体温过高,腹泻和癫痫发作。目前的研究表明,对于任何SSRI药物,血清素毒性的任何特定临床症状的出现均没有增加。在人们中,据报道西酞普兰具有增加的心电图异常风险。 SSRI中毒的诊断基于病史,临床体征和对治疗的反应。目前尚无单一临床试验可确认SSRI中毒。这种中毒的治疗目标是支持动物,防止药物进一步吸收,支持中枢神经系统,控制体温过高以及停止任何癫痫发作活动。尽管出现5-羟色胺综合征,但过量服用SSRIs的相对安全性使其比其他抗抑郁药更为理想。接受治疗的动物的预后极好。在一项回顾性研究中,没有313只SSRI中毒的狗死亡。 SSRI中毒不会导致特征性或典型的组织病理学损害。 SSRI过量的鉴别诊断必须包括摄入其他血清素药物,例如苯哌啶类阿片类药物(芬太尼和曲马多),米氮平,丁螺环酮,阿米拉和氯苯那敏

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号